Table 4. Six Patients and the Management of Adverse Events.
No | Age/sex | Presentation | H-H | Locations | Saccular/wide-neck | Size | StentType | Adverse Events | Measures | Occlusion Grade | Follow-upmRS |
1 | 65/F | SAH | II | MCA-bifur | Yes/Yes | Small | ST+ST | Thrombus | Tirofiban+Stenting | Class I | 2 |
2 | 53/F | Incidental | 0 | PComA | Yes/Yes | Tiny | ST | Thrombus | Tirofiban | Class I | 1 |
3 | 56/F | SAH | II | PComA | Yes/Yes | Small | ST | Infarction | No | Class II | 2 |
4 | 55/M | SAH | IV | AComA | Yes/Yes | Small | ST | Infarction | No | Class I | 4 |
5 | 48/M | SAH | I | MCA-bifur | Yes/Yes | Small | ST | Rupture | Heparinisation was reversed +total occlusion+ fasudil | Class I | 1 |
6 | 49/F | Incidental | 0 | PComA | Yes/Yes | Small | ST | Rupture | Heparinisation was reversed +total occlusion | Class I | 1 |
F, Female; M, Male; SAH, subarachnoid haemorrhage; H-H, Hunt-Hess Scale; MCA, middle cerebral artery; Bifur, Bifurcation; PComA, posterior communicating artery; AComA, the anterior communicating artery; ST, Solitaire.